Equity Research Analyst - US Healthcare

Lazard

$200K — $250K *
Healthcare
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • 10+ years of research experience in pharmaceuticals or biotechnology.
  • 5+ years of buy-side capital commitment experience.
  • Strong knowledge of drug development, FDA pathways, and commercialization.
  • Expert ability in financial modeling, including DCF and scenario analysis.
  • Long-only investment focus with an emphasis on business durability and multi-year growth.
  • Demonstrated track record of idea generation with evidence of outcomes.
  • Clear and concise communicator, skilled in articulating investment theses.

Responsibilities

  • Own and maintain a comprehensive view on US pharma and biotech sectors.
  • Source and defend long-term investment ideas with clear growth strategies.
  • Engage in rigorous debates with PMs and analysts to refine investment theses.
  • Monitor investment positions for key catalysts and communicate changes promptly.
  • Develop and maintain a strong network of industry experts and KOLs.
  • Utilize AI tools for effective research and to enhance analytical efficiency.
  • Contribute insights and frameworks to improve the overall research platform.

Benefits

  • Comprehensive health and wellness programs to support employee well-being.
  • Support for balancing career, family, and community commitments.
  • Focused investment in employee career development and personalization.
Full Job Description
Job Description

Lazard Asset Management is hiring an experienced US Healthcare Equity Research Analyst.

Backed by a 175-year heritage of independent, research-driven investing, Lazard offers analysts a rare combination: the resources and global reach of a scaled platform with the intellectual latitude and collaborative culture of a boutique. For researchers who want their ideas to matter at scale - and to help shape a platform building its next chapter of growth - there has never been a more compelling moment to build a career here.

We'll trust you to:

  • Own the sector. Build and maintain a differentiated view on US pharma and biotech, including pipeline economics, patent cliffs and LOE exposure, launch trajectories, pricing and reimbursement policy, and M&A/BD capital allocation.
  • Generate investable ideas. Source, underwrite, and defend long ideas with a multi-year horizon, framing the durability of growth, returns on invested capital, and the gap between market expectations and your own.
  • Debate rigorously. Engage PMs and fellow analysts directly - pressure-test your thesis, challenge theirs, and update views as evidence changes. Intellectual honesty on what you got wrong matters as much as conviction on what you got right.
  • Monitor positions actively. Track catalysts (clinical readouts, FDA actions, policy shifts, earnings) and communicate thesis-changing developments quickly and unambiguously.
  • Maintain an expert network. Develop relationships with management teams, KOLs, physicians, payers, regulatory and policy experts, and industry consultants to source information ahead of consensus.
  • Advance the toolkit. Apply AI and modern research tooling to accelerate information synthesis and expand coverage depth, freeing more time for high-value judgment and portfolio construction.
  • Contribute to the platform. Share frameworks and sector read-throughs that make adjacent analysts and PMs better.


You'll need to have:

  • 10+ years research experience covering pharmaceuticals, biotechnology, or broader healthcare,
  • 5 or more years of track record committing capital on the buy side.
  • Genuine command of drug development and commercialization - clinical trial design and endpoints, FDA pathways, IP and exclusivity, and US payer and pricing dynamics.
  • Strong fundamental modeling and valuation skills, including DCF, sum-of-the-parts/asset-level valuation, and scenario analysis.
  • A long-only, quality investing orientation: focused on business durability, competitive moats, financial productivity, and multi-year compounding rather than short-term trading.
  • Evidence of an idea-generation track record you can walk through - theses, outcomes, and lessons from the misses.
  • Clear, concise written and verbal communication; able to state a thesis, the variant view, and the risk in a few sentences.
  • Bachelor's degree in life sciences, finance, economics, or a related field.
    Preferred
  • Prior experience in a collaborative research platform serving multiple portfolio strategies.
  • Practical fluency with AI-assisted research workflows, alternative data (prescription, claims, clinical trial databases), or Python/SQL for analysis.
  • Advanced degree (MD, PhD, PharmD, MBA) or CFA charter.
  • Exposure to global healthcare beyond the US, or to medtech, life science tools, and managed care as adjacent coverage.


What we offer

We strive to enhance the total health and well-being of our employees through comprehensive, competitive benefits. Our goal is to offer a highly individualized employee experience that enables you to balance your commitments to career, family, and community. When you work for Lazard, you are working for an organization that cares about your unique talents and passions, and will continue to invest in the development of your career.

We expect the base salary range for this role to be approximately $200,000 - 250,000 USD. Various factors contribute to determining the actual base compensation offered, including but not limited to the applicant's years of relevant experience, career tenure, qualifications, level of education attained, certifications or other professional licenses held, relevant skills for the role. Base salary is one component of Lazard Asset Management's compensation package, which also includes comprehensive benefits and may include incentive compensation.

Does this sound like you?

Apply! We'll get in touch on the next steps.

#LAM

#LI-AK1

Similar Jobs

More Healthcare Jobs

Find similar Equity Research Analyst - US Healthcare jobs: